• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Boehringer Ingelheim Corporation 12-Jul-01 -DETAIL

Letter Issue Date Company Name Issuing Office Subject
07/12/2001 Boehringer Ingelheim Corporation Cincinnati District Office Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated
Persons with disabilities having problems accessing the above pdf file may call 301-827-6567 for assistance